| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.5 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |